Torre syndrome
Torre syndrome, also known as Muir-Torre syndrome (MTS), is a rare genetic disorder characterized by the co-occurrence of sebaceous gland neoplasms and/or keratoacanthomas and internal malignancies. It is a subtype of Lynch syndrome, a hereditary nonpolyposis colorectal cancer syndrome.
Etiology[edit | edit source]
Torre syndrome is caused by mutations in the same DNA mismatch repair genes that cause Lynch syndrome, namely MLH1, MSH2, MSH6, and PMS2. These genes are responsible for correcting errors that occur during DNA replication. Mutations in these genes lead to an increased risk of developing certain types of cancer.
Clinical Features[edit | edit source]
The most common clinical feature of Torre syndrome is the presence of sebaceous neoplasms, which are benign tumors of the sebaceous glands. These can occur anywhere on the body but are most commonly found on the face. Keratoacanthomas, rapidly growing, benign skin tumors, are also commonly seen in individuals with Torre syndrome.
In addition to skin manifestations, individuals with Torre syndrome are at an increased risk of developing internal malignancies. The most common of these are colorectal cancer and endometrial cancer, but other cancers such as stomach, ovary, small intestine, hepatobiliary tract, kidney, brain, and upper urinary tract cancers have also been reported.
Diagnosis[edit | edit source]
Diagnosis of Torre syndrome is based on clinical criteria, which include the presence of one or more sebaceous neoplasms or keratoacanthomas and at least one internal malignancy. Genetic testing can confirm the diagnosis by identifying mutations in the MLH1, MSH2, MSH6, or PMS2 genes.
Treatment[edit | edit source]
Treatment for Torre syndrome is primarily focused on managing the individual's risk of developing cancer. This may include regular cancer screenings, prophylactic surgeries, and lifestyle modifications. Skin lesions are typically removed surgically.
Prognosis[edit | edit source]
The prognosis for individuals with Torre syndrome largely depends on the type and stage of any internal malignancies. With early detection and appropriate treatment, the prognosis can be quite good.
See Also[edit | edit source]
Dermatology and Rheumatologic diseases A - Z
A | B | C | E | F | G | H | I | J | K | L | M | O | P | R | S | T | V
Torre syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD